Aarti Pharmalabs Ltd share price logo

Aarti Pharmalabs Ltd

NSE: AARTIPHARM

BSE: 543748

Small Cap

Pharma Sector

₹711.75

-7.50

(-1.04%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Aarti Pharmalabs Stock Performance

as on May 15, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹705.60
    ₹725.30
    downward going graph

    0.86%

    Downside

    1.90%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹585.00
    ₹971.00
    downward going graph

    17.81%

    Downside

    36.42%

    Upside

    downward going graph

Aarti Pharmalabs share price movements today

Previous Close
₹719.25
Open
₹719.25
Volume
1.34L
Upper Circuit
₹863.10
Lower Circuit
₹575.40
Day's Low - High
₹705.60 - ₹725.30
52 Week Low - High
₹585.00 - ₹971.00

Aarti Pharmalabs Historical Returns

1 Month Return
+ 1.68 %
3 Month Return
+ 0.13 %
1 Year Return
-10.64 %
3 Year Return
+ 94.18 %
5 Year Return
+ 146.92 %

Aarti Pharmalabs Fundamentals

as on May 15, 2026 at 4:01 pm IST

Market Cap

₹6,452.57 Cr

Return on Equity (ROE)

14.85

PE Ratio (TTM)

30.18

Return on capital employed (ROCE)

17.33

Industry PE ratio

45.6

Beta (LTM)

1.13

P/B Ratio

3.68

Dividend Yield

0.67

PEG Ratio

-7.68

Quarterly Earnings Growth YOY

-35.18

EPS (TTM)

30.06

Sector

Pharmaceuticals

Book Value

219.55

Aarti Pharmalabs Stock Valuation

as on May 15, 2026 at 4:01 pm IST

Aarti Pharmalabs in the last 5 years

  • Overview

  • Trends

Lowest (11.23x)

February 2, 2023

Today (30.18x)

May 15, 2026

Industry (45.60x)

May 15, 2026

Highest (34.19x)

May 4, 2026

LowHigh

Today’s Price to Earnings Ratio: 30.18x

Aarti Pharmalabs Technical Analysis

Track how Aarti Pharmalabs technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish8
Bullish5
Neutral2

Oscillators

Name

Value

Action

MACD level (12,26)
-1.5
Bullish
CCI (20)
189.13
Bearish
RSI (14)
42.88
Neutral
Momentum (10)
0.85
Bullish
ADI (14)
59.53
Bullish
Ultimate Oscillator (7,14,28)
43.12
Neutral

Moving Averages

Name

Value

Action

SMA (20)
711.4
Bullish
EMA (20)
712.26
Bearish
VWMA (20)
711.2
Bullish
SMA (50)
716.84
Bearish
EMA (50)
715.49
Bearish
SMA (200)
718.35
Bearish
EMA (200)
718.14
Bearish
KAMA (200)
713.37
Bearish
DEMA (200)
718.45
Bearish

Aarti Pharmalabs Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Aarti Pharmalabs with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Aarti Pharmalabs Ltd image
Aarti Pharmalabs Ltd
BUY6,452.5729.38%0.592722,115
Fredun Pharmaceuticals Ltd image
Fredun Pharmaceuticals Ltd
NA1,304.5584.93%0.7719453
Ind-Swift Laboratories Ltd image
Ind-Swift Laboratories Ltd
NA1,162.6514.22%0.52250561
Astrazeneca Pharma India Ltd image
Astrazeneca Pharma India Ltd
NA21,171.2524.51%0.001151,716
Lincoln Pharmaceuticals Ltd image
Lincoln Pharmaceuticals Ltd
NA1,290.3220.33%0.5082623
See all

Market expectation of Aarti Pharmalabs Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Aarti Pharmalabs Stock’s Investor Sentiment and Interest

Search interest for Aarti Pharmalabs Ltd Stock has increased by 72% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:72% versus previous 30 day period

Aarti Pharmalabs Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
458.36
439.8
448.69
505.77
555.49
458.03
537.78
563.78
386.19
418.33
432.27
Other Income
0.48
0.98
1.39
2.03
2.22
4.48
5.03
-1.61
1.6
0.05
4.55
Total Income
458.84
440.78
450.08
507.8
557.71
462.51
542.81
562.17
387.79
418.39
436.83
Expenses
373.49
351.81
353.01
388.25
459.03
364.35
409.17
418.15
292.74
344.26
332.76
Operating Profit
84.87
87.99
95.68
117.52
96.46
93.68
128.61
145.63
93.45
74.07
99.51
Operating Profit Margin %
18.52%
20.01%
21.32%
23.24%
17.36%
20.45%
23.91%
25.83%
24.2%
17.71%
23.02%
Profit Before Interest, Tax and Depreciation
85.35
88.97
97.07
119.55
98.68
98.16
133.64
144.02
95.04
74.13
104.07
Interest
4.17
3.89
4.48
4.68
4.83
5.51
9.97
6.58
6.79
10.67
12.58
Depreciation
17.2
18.14
18.77
19.12
20.17
20.88
23.04
22.82
22.79
24.77
28.62
Profit Before Tax
63.98
66.94
73.82
95.75
73.68
71.77
100.63
114.62
65.46
38.69
62.87
Tax Paid
16.89
15.15
21.06
30.5
18.23
17.14
26.64
26.27
15.95
10.77
14.92
Profit After Tax
47.09
51.8
52.76
65.25
55.45
54.62
73.99
88.34
49.5
27.92
47.96
Total Net profit including share of profit / Loss from associate company
47.09
51.8
52.76
65.25
55.45
54.62
73.99
88.34
49.5
27.92
47.96
EPS
5.2
5.72
5.82
7.2
6.12
6.03
8.16
9.75
5.46
3.08
5.29
Actual EPS
5.2
5.72
5.82
7.2
6.12
6.03
8.16
9.75
5.46
3.08
5.29
Adjusted EPS
5.2
5.72
5.82
7.2
6.12
6.03
8.16
9.75
5.46
3.08
5.29
Diluted EPS
5.2
5.72
5.82
7.2
6.12
6.02
8.16
9.74
5.46
3.08
5.29

Aarti Pharmalabs Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
-
1,199.94
1,945.23
1,852.61
2,115.07
Other Income
-
2.51
2.32
4.9
10.12
Total Income
-
1,202.45
1,947.55
1,857.5
2,125.19
Expenses
-
992.99
1,603.19
1,466.56
1,650.7
Operating Profit
-
206.95
342.04
386.05
464.37
Operating Profit Margin %
0%
17.25%
17.58%
20.84%
21.96%
Profit Before Interest, Tax and Depreciation
-
209.46
344.36
390.94
474.49
Interest
-
11.96
21.05
17.21
26.9
Depreciation
-
42.12
62.54
73.24
86.9
Profit Before Tax
-
155.38
260.77
300.49
360.69
Tax Paid
-
33.13
67.28
83.59
88.29
Profit After Tax
-
122.25
193.49
216.9
272.4
Total Net profit including share of profit / Loss from associate company
-
122.25
193.49
216.9
272.4
EPS
-0.18
13.49
21.35
23.93
30.06
Actual EPS
-0.18
13.49
21.35
23.93
30.06
Adjusted EPS
-0.18
13.49
21.35
23.93
30.06
Diluted EPS
-0.18
13.49
21.35
23.93
30.04

Aarti Pharmalabs Ltd Cash Flow

Figures in Rupees Crores

Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
-
-43.7
250.12
216.35
331.56
Cash Flow from Investing Activities
-
-138.73
-157.8
-214.57
-413.9
Cash Flow from Financing Activities
-
260.38
-163.47
9.72
65.43
Net Cash Flow
-
77.94
-71.15
11.51
-16.9

Mutual Funds that own Aarti Pharmalabs Stock

Check out the Mutual Funds with significant holdings in Aarti Pharmalabs.

Aarti Pharmalabs Corporate Actions

View detailed summary of the earnings and dividend history of Aarti Pharmalabs.

  • Aarti Pharmalabs Ltd Earnings Results

    Aarti Pharmalabs Ltd’s net profit fell -35.18% since last year same period to ₹47.96Cr in the Q3 2025-2026. On a quarterly growth basis, Aarti Pharmalabs Ltd has generated 71.78% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Aarti Pharmalabs Ltd Dividends February,2026

    In the quarter ending December 2025, Aarti Pharmalabs Ltd has declared dividend of ₹1.50 per share on 09 Feb 2026 - translating a dividend yield of 0.56%.

    Read More about Dividends

Indices Featuring Aarti Pharmalabs Stock

Check stock indices that include Aarti Pharmalabs.

BSE Healthcare

₹47,193.13

0.18 (▲84.87%)

Insights on Aarti Pharmalabs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 7.68% to 8.39% in Mar 2026 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 27.92 Cr → 47.96 Cr (in ₹), with an average increase of 41.8% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 387.79 Cr → 436.83 Cr (in ₹), with an average increase of 5.8% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, AARTIPHARM stock has moved down by -6.1%

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 1.09% to 0.80% in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 41.54% to 41.11% in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 43.10% to 43.08% in Mar 2026 quarter

About Aarti Pharmalabs Ltd

Aarti Pharmachem Limited was incorporated as a Public Limited Company in 2019. The Company is engaged in manufacturer of Active Pharmaceutical Ingredients API Pharmaceutical Intermediates New Chemical Entities NCE and Xanthine Derivatives situated in India.In 2001 the Company commissioned first API manufacturing Unit in Dombivali Unit 1 and started Xanthine Unit further it commissioned first API manufacturing Unit 4 in Tarapur for Regulated Markets in 2005 commissioned Caffeine production at Unit 5 with a capacity of 100 Metric Tonnes MT per month in 2016. It expanded block for CSD Vapi and API Tarapur units in 2022.The Scheme of Arrangement for the demerger of Pharma Business Undertaking from Aarti Industries Limited into its wholly owned subsidiary Aarti Pharmalabs Limited was effective on October 17 2022 and operational from July 1 2021. Pursuant to the said Demerger Scheme Aarti Industries Limited hived off its Pharmaceutical Division into a separate entity Aarti Pharmalabs Limited and accordingly all the assets and liabilities pertaining to the Pharma Business Undertaking got transferred and vested into the Company effective from the above said Date.Thereafter the Company in 2023 commercialised Block V at Tarapur Unit 4. Again it enhanced Xanthine capacity to 5000 TPA in 2023.90626008 Equity Shares of Rs 5/ each got listed effective January 30 2023..

Revenue: ₹432.27Cr as on December 2025 (Q3 FY26)
Net Profit: ₹47.96Cr as on December 2025 (Q3 FY26)
Listing date: 30 Jan, 2023
Chairperson Name: Rashesh C Gogri
OrganisationAarti Pharmalabs Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEORashesh C Gogri
E-voting on sharesClick here to vote

FAQs

What is Aarti Pharmalabs share price today?

Aarti Pharmalabs share price today stands at ₹711.75 as on at the close of the market. Aarti Pharmalabs share today touched a day high of ₹725.3 and a low of ₹705.6.

What is the 52 week high and 52 week low range for Aarti Pharmalabs share?

Aarti Pharmalabs touched a 52 week high of ₹971 and a 52 week low of ₹585. Aarti Pharmalabs share price today i.e. is closed at ₹711.75, which is -26.70% down from its 52 week high and 21.67% up from its 52 week low.

What is Aarti Pharmalabs's market capitalisation today?

Aarti Pharmalabs market capitalisation is ₹6,452.57 Cr as on .

How to buy Aarti Pharmalabs shares?

To buy Aarti Pharmalabs shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for AARTIPHARM or Aarti Pharmalabs Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Aarti Pharmalabs shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Aarti Pharmalabs trading volume today?

Aarti Pharmalabs trading volume is 1.34L as on . This means that 1.34L shares of Aarti Pharmalabs were bought and sold on the stock market during today's trading session.